At OncoFirm Diagnostics Corp. (a registered Delaware Corporation) Cancer Rapid Tests, we are revolutionizing cancer diagnostics through cutting-edge lateral flow assay (LFA) technology, specializing in rapid test development for early cancer detection. Our proprietary diagnostic solutions utilize various antigens, with highly specific biomarkers linked to cancer progression, to provide accurate, fast, and accessible screening tools. Available to hospitals, clinics, and diagnostic labs, cancer screening and progression programs, research in oncology and infectious diseases…                                       Investor Disclaimer (1)

Advanced Antigen Technology for Superior Lateral Flow Cancer Screening

OnCOFIRM Diagnostics - Cancer Rapid Tests
Our cutting-edge antigen technologies ensure precise and reliable test results, enabling early cancer detection across various types while also monitoring treatment responses effectively.
Enhancing Cancer Diagnosis

Revolutionizing Cancer Diagnostics through Cutting-Edge Technology

Our rapid lateral flow assay technology provides quick insights within minutes for timely interventions.

  • Cutting-edge Cancer Diagnostics
  • Rapid Test Development
  • Highly Specific Biomarkers
  • Target immunotherapies
  • Detected in circulating tumor cells
Learn More
Enhancing Cancer Diagnosis

Revolutionizing Cancer Diagnostics through Cutting-Edge Technology

OncoFirm Diagnostics pioneers rapid cancer tests with advanced technology.

Learn More
rapid cassette dropper steps
Accurate Testing

Ensure precise cancer diagnostics

rapid cassette dropper
Fast Results

Get fast and actionable results

electronic cassette reader
Specialized Biomarkers

Leverage specific cancer biomarkers